Source: Ferret

Cancer Therapeutics CRC : Australian cancer drug licensed in $730M deal

A promising new cancer drug, developed in Australia by the Cancer Therapeutic, has been licensed to US pharmaceutical company Merck for $730 million.More...The post Australian cancer drug licensed in $730M deal originally appeared on Ferret.com.au

Read full article »
Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more